RT Journal Article
SR Electronic
T1 Association between social determinants of health and cardiovascular and cancer mortality in cancer survivors: a nationally representative cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.08.24307071
DO 10.1101/2024.05.08.24307071
A1 Chan, Jeffrey Shi Kai
A1 Satti, Danish Iltaf
A1 Ching, Yat Long Anson
A1 Lee, Quinncy
A1 Dee, Edward Christopher
A1 Ng, Kenrick
A1 Chou, Oscar Hou-In
A1 Liu, Tong
A1 Tse, Gary
A1 Lai, Agnes
YR 2024
UL http://medrxiv.org/content/early/2024/05/09/2024.05.08.24307071.abstract
AB Although it is known that social deprivation is associated with higher risks of cardiovascular and cancer mortality in the general population, these associations may not be directly applicable to cancer survivors. Using data from the National Health Interview Survey (NHIS) 2013-2017 with follow-up till the end of 2019, we examined the associations between social determinants of health (SDOH) and the risk of all-cause, cardiovascular, and cancer mortality in cancer survivors, with separate modelling in individuals without cancer for comparison. Two Cox regression models were fitted for each outcome, the first being adjusted for demographics and the second being additionally adjusted for comorbidities and risk factors. Altogether, 37,882 individuals were analysed (representing a weighted population of 57,696,771), including 4179 cancer survivors and 33,703 individuals without cancer. Amongst cancer survivors, worse SDOH was associated with higher all-cause, cardiovascular, and cancer mortality when adjusted for demographics, which were attenuated but remained significant when further adjusted for comorbidities and risk factors. Amongst individuals without cancer, worse SDOH was associated with higher all-cause and cardiovascular mortality only when adjusted for demographics, but not when further adjusted for comorbidities and risk factors. These suggested that in cancer survivors, associations between SDOH and cardiovascular/cancer mortality may be driven by factors beyond comorbidities and risk factors, contrasting individuals without cancer in whom similar associations were probably driven mostly by comorbidities and risk factors.Competing Interest StatementECD is funded in part through the Cancer Center Support Grant from the National Cancer Institute (P30 CA008748). All other authors report no conflict of interest.Funding StatementThis work is supported by a Research Impact Fund awarded to GT by the Hong Kong Metropolitan University (Project Reference No. RIF/2022/2.2).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data underlying this study are publicly available and accessible online at https://nhis.ipums.org/nhis/ .I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data underlying this study are publicly available and accessible online at https://nhis.ipums.org/nhis/.